SASKATOON, Saskatchewan, September 28, 2024--ZYUS Life Sciences Corporation (the "Company") (TSX-V: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announces that an independent director of the Company (the "Lender") has agreed to advance a CAD$1,000,000 unsecured loan (the "Loan") to the Company with a closing date on or about October 1, 2024 and subject to the Company f
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...